Brian Swann

Brian Swann serves as a procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical biomedical and diagnostic capabilities. He manages a diverse portfolio of contracts focused on laboratory diagnostics, pharmaceutical preparation, and analytical instrumentation essential for infectious disease surveillance and response. His work directly enables CDC’s scientific operations by securing high-integrity products and services that support national public health infrastructure, including rapid testing platforms, clinical research tools, and data-driven analytical systems. Swann maintains consistent partnerships with leading vendors in the public health sector, including General Dynamics Information Technology, Cepheid, GlaxoSmithKline, and MRIGLOBAL. These relationships reflect a focus on established industry leaders with proven capabilities in manufacturing diagnostic reagents, deploying laboratory automation systems, and delivering technical consulting for complex health surveillance initiatives. His contracting approach prioritizes reliability, regulatory compliance, and technical scalability, ensuring that procurements align with CDC’s operational tempo during public health emergencies. His procurement patterns show a strong preference for open competition, with 96.7% of awards issued without set-asides, indicating a focus on technical merit and mission-critical capability over socioeconomic preferences. While small business participation is limited at 3.3%, it is strategically targeted toward high-impact, specialized solutions where small firms can deliver unique innovation in diagnostic or analytical domains. Swann’s primary procurement focus lies in NAICS 325412 (pharmaceutical preparation), 325413 (in-vitro diagnostic substances), and 334516 (analytical laboratory instruments), reflecting deep expertise in procuring clinical-grade reagents, molecular diagnostic platforms, and precision instrumentation. His domain knowledge spans virology, epidemiological data systems, and laboratory accreditation standards, ensuring acquisitions meet stringent federal health and safety requirements.